US2012009164A1PendingUtilityA1
Increasing Probiotic Growth Rate and Activity Using Prebiotic Composition
Est. expiryJul 9, 2030(~4 yrs left)· nominal 20-yr term from priority
A61P 31/10A61P 3/02A61K 35/745A61P 1/12Y10S435/854A61K 31/66A61K 31/685Y10S435/853A61P 1/00A61K 36/28A61P 1/04A61K 31/201A61P 1/10A61K 35/747A61P 1/14
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Naturally occurring lecithins and/or oleic acid stimulate the growth and lactic acid producing activity of Lactobacillus and Bifidobacterium species of probiotic bacteria, and replace polysorbate 80 for those products. They can be used in naturally occurring form, or where they are to be combined with probiotics in a carrier, or they can be treated to yield a stable powdered form of these naturally oily compounds. They can be sold as combined prebiotic/probiotic formulations in the same carrier, or sold as separate dietary supplements, e.g., in capsule or tablet form, to be used with the probiotic formulation as desired.
Claims
exact text as granted — not AI-modified1 . A method of enhancing growth and activity of Lactobacillus and/or Bifidobacterium species in the absence of polysorbate 80, comprising:
administering Lactobacillus and/or Bifidobacterium species with lecithin or oleic acid, or combinations of lecithin and oleic acid.
2 . The method of claim 1 wherein the lecithin or oleic acid, or the combinations of lecithin and oleic acid, are in a capsule or other carrier together with the Lactobacillus and/or Bifidobacterium species.
3 . The method of claim 1 wherein the lecithin is soy lecithin or sunflower lecithin.
4 . The method of claim 1 wherein the lecithin or oleic acid, or the combinations of lecithin and oleic acid, are adsorbed to and adsorbent which is one or more of calcium silicate, silicon dioxide, silica, clays and food starches.
5 . The method of claim 4 wherein the adsorbed lecithin or oleic acid, or the combinations of lecithin and oleic acid, are also mixed with microcrystalline cellulose.
6 . The method of claim 4 wherein the adsorbed lecithin or oleic acid, or the combinations of lecithin and oleic acid, are also mixed with silica.
7 . The method of claim 1 wherein the lecithin or oleic acid, or the combinations of lecithin and oleic acid, are non-aqueous.
8 . The method of claim 4 wherein the food starches are corn starch or potato starch.
9 . The method of claim 4 wherein the clays are food grade.
10 . The method of claim 9 wherein the clays are kaolin or sodium bentonite.
11 . The method of claim 5 wherein the microcellulose is between 10% to 300% of the weight of the adsorbent.
12 . The method of claim 6 wherein the silica is 0.25 to 2% of the combined weight of the lecithin, oleic acid, adsorbent and microcrystalline cellulose.
13 . The method of claim 4 wherein the combined weight of the lecithin and oleic acid is 5 to 40% of the total weight of the lecithin, oleic acid, adsorbent and microcrystalline cellulose.
14 . The method of claim 1 wherein the lecithin and oleic acid are in liquid form and are not in the same capsule as the probiotics.
15 . The method of claim 14 further including Vitamin E.
16 . The method of claim 15 wherein Vitamin E is the D, L or a mixture of the D and L isomers.
17 . The method of claim 15 wherein Vitamin E is 0.01%-5.0% by weight of the final formulation.
18 . The method of claim 17 wherein the Vitamin E is 0.1% by weight of the final formulation.
19 . The method of claim 14 wherein the weight ratio of the lecithin to oleic acid is from 60:40 to 95:5.
19 . The method of claim 19 wherein the weight ratio of the lecithin to oleic acid is 90:10.
20 . The method of claim 1 wherein the strains of Lactobacillus include Lactobacillus acidophilus NCFM, Lactobacillus rhamnosus Lr-32 , Lactobacillus paracasei Lpc-37, and Lactobacillus salavarius Ls-33.
21 . The method of claim 1 wherein the Bifidobacterium is Bifidobacterium lactis Bl-04 (BL-34).
22 . The method of claim 1 wherein the Lactobacillus and/or Bifidobacterium with lecithin or oleic acid, or combinations of lecithin and oleic acid, is administered to a human being or other mammal.
23 . The method of claim 1 wherein the Lactobacillus and/or Bifidobacterium is administered before or after administration of the lecithin or oleic acid, or before or after administration of the combinations of lecithin and oleic acid.
24 . The method of claim 1 wherein carbohydrates are administered with the lecithin or oleic acid, or with the combinations of lecithin and oleic acid.
25 . The method of claim 24 wherein 50 g of carbohydrate are administered with the lecithin or oleic acid, or with the combinations of lecithin and oleic acid.
26 . The method of claim 1 wherein 10 to 100 mg of the lecithin or oleic acid, or 10 to 100 mg of the combinations of lecithin and oleic acid, are administered for each dose of the Lactobacillus and/or Bifidobacterium.
27 . The method of claim 16 wherein 20 mg of the lecithin or oleic acid, or 20 mg of the combinations of lecithin and oleic acid, are administered for each dose of the Lactobacillus and/or Bifidobacterium.
28 . The method of claim 1 including sunflower lecithin or soy lecithin and oleic acid.
29 . The method of claim 28 wherein the lecithin is sunflower lecithin and the formulation also includes oleic acid.
30 . The method of claim 28 or 29 wherein the weight ratio of sunflower lecithin to oleic acid is 90:10.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.